Table 1 Clinicopathological characteristics of the enrolled patients
From: Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients
Parameter | No of patients (n = 296) | % |
|---|---|---|
Neutrophil / Lymphocyte Ratio | ||
NLR ≤ 4.7 | 260 | 87.8 |
NLR > 4.7 | 36 | 12.2 |
Gender | ||
Female | 114 | 38.5 |
Male | 182 | 61.5 |
Age (years) | ||
Median + IR | 72 (63–77) | |
Age > 72 | ||
Age ≤ 72 | 157 | 53 |
Age > 72 | 139 | 47 |
Primary tumor | ||
Right colon | 103 | 34.8 |
Left colon | 62 | 21 |
Rectum | 131 | 44.2 |
Differentiation | ||
Low | 63 | 21.3 |
Medium + High | 233 | 78.7 |
Τ | ||
T1 | 18 | 6 |
T2 | 57 | 19.2 |
T3 | 195 | 65.9 |
T4 | 26 | 8.8 |
Ν | ||
N0 | 187 | 63.2 |
N1 | 77 | 26 |
N2 | 32 | 10.8 |
No of lymph nodes harvested | ||
Median + IR | 19 (14–27.5) | |
No of lymph nodes harvested | ||
Lymph nodes ≥12 | 261 | 88.2 |
Lymph nodes < 12 | 35 | 11.8 |
Stage | ||
Stage I | 61 | 20.6 |
Stage II | 126 | 42.6 |
Stage III | 109 | 36.8 |
Perineural invasion | ||
No | 273 | 92.2 |
Yes | 23 | 7.8 |
Vascular invasion | ||
No | 253 | 85.5 |
Yes | 43 | 14.5 |
Lymphatic invasion | ||
No | 257 | 86.8 |
Yes | 39 | 13.2 |
Follow-up (months) | ||
Median + IR | 45 (27–68.5) | |
Site of recurrence | ||
Distant | 16 | 51.6 |
Local | 15 | 48.4 |
Follow up | ||
Alive with recurrence | 8 | 2.7 |
Deaths related to the recurrence | 23 | 7.8 |
Deaths unrelated to the disease | 45 | 15.2 |
Alive | 220 | 74.3 |